WALTHAM, Mass.–(BUSINESS WIRE)–Now that the FDA has approved two different COVID-19 vaccines for emergency use, Annie Lambert, PharmD, BCSCP, clinical program manager, Wolters Kluwer, Health advises...
Vancouver, BC, Nov 2, 2020 - (ACN Newswire) - BioVaxys Technology Corp. (CSE: BIOV) ("BioVaxys" or "the Company"), a world leader in haptenized protein vaccine...